Truscreen Ltd

Healthcare AU TRU

0.019AUD
-(-%)

Last update at 2024-05-20T00:37:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.020.03
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -2.40184M -7.89267M -3.49001M -5.19672M -3.38045M
Minority interest - - - - -
Net income -2.40184M -7.89267M -3.49001M -5.19672M -3.38045M
Selling general administrative 1.41M 1.54M 1.62M 2.16M 2.21M
Selling and marketing expenses 0.72M 0.71M 0.62M 0.43M -
Gross profit 0.46M 0.52M 0.40M 0.52M 0.53M
Reconciled depreciation - 0.59M 0.65M 0.60M 0.57M
Ebit -2.19648M -8.86659M -3.45545M -2.74476M -2.95702M
Ebitda -2.94186M -8.27387M -2.80886M -2.14693M -2.78695M
Depreciation and amortization - 0.59M 0.65M 0.60M -
Non operating income net other - - - - -
Operating income -2.94186M -8.86659M -3.45545M -2.74476M -4.27790M
Other operating expenses 4.60M 10.55M 5.30M 5.41M 0.02M
Interest expense - 0.00000M 0.03M 0.07M 0.03M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00330M 0.00037M 0.00182M 0.00887M 0.01M
Net interest income 0.00330M 0.00037M -0.03274M -0.06309M -0.01587M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.00037M 0.74M 1.44M -
Total revenue 1.66M 1.68M 1.13M 1.29M 1.86M
Total operating expenses 3.40M 9.39M 4.56M 4.64M -
Cost of revenue 1.20M 1.16M 0.73M 0.77M 1.33M
Total other income expense net 0.54M 0.97M 0.71M -1.01479M 0.91M
Discontinued operations - - - - -
Net income from continuing ops -2.40184M -7.89267M -3.49001M -5.19672M -3.38045M
Net income applicable to common shares -2.40184M -7.89267M -3.49001M -5.19672M -3.38045M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 3.47M 4.39M 12.00M 8.07M 12.55M
Intangible assets - - 5.00M 5.23M 8.26M
Earning assets - - - - -
Other current assets 0.03M 0.04M 0.04M 0.02M 0.81M
Total liab 0.93M 0.99M 0.70M 0.83M 1.22M
Total stockholder equity 2.54M 3.40M 11.31M 7.24M 11.32M
Deferred long term liab - - 1.44M 1.51M 2.38M
Other current liab 0.09M 0.14M 0.21M 0.38M -
Common stock 36.10M 34.55M 34.55M 27.49M 26.42M
Capital stock 36.10M 34.55M 34.55M 27.49M 26.42M
Retained earnings -33.32081M -31.22497M -23.33229M -19.84228M -14.64556M
Other liab 0.04M 0.04M 0.04M 0.05M 0.05M
Good will - - - - -
Other assets - - 1.44M 1.51M 2.38M
Cash 2.16M 2.80M 5.26M 1.02M 1.74M
Cash and equivalents - - - - -
Total current liabilities 0.89M 0.95M 0.66M 0.79M 1.17M
Current deferred revenue - - - - -
Net debt -2.16047M -2.79700M -5.25507M -0.61387M -
Short term debt - - - 0.41M 0.63M
Short long term debt - - - 0.41M 0.63M
Short long term debt total - - - 0.41M -
Other stockholder equity -0.23430M 0.07M 0.09M -0.40870M -0.45480M
Property plant equipment - - 0.31M 0.30M 0.38M
Total current assets 3.47M 4.39M 6.70M 2.55M 3.90M
Long term investments - - - - -
Net tangible assets 2.54M 3.40M 7.75M 3.52M 5.44M
Short term investments - - - - -
Net receivables 0.51M 0.88M 0.56M 0.87M 1.36M
Long term debt - - - - -
Inventory 0.56M 0.50M 0.73M 0.50M 0.78M
Accounts payable 0.80M 0.81M 0.45M 0.29M 0.44M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.23430M 0.07M 0.09M -0.40870M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M 5.31M 5.53M 8.64M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.04970M -0.00266M -0.09752M - -0.41003M
Change to liabilities -0.00712M 0.35M 0.16M -0.14389M 0.02M
Total cashflows from investing activities -0.04970M -0.00266M -0.09752M -0.09752M -0.41003M
Net borrowings - - -0.41028M -0.21622M 0.63M
Total cash from financing activities 1.55M 1.55M 6.65M 0.85M 3.61M
Change to operating activities 0.19M -0.16745M 0.24M 0.25M 0.43M
Net income -2.40184M -7.89267M -3.49001M -5.19672M -3.38045M
Change in cash -0.63654M -2.45807M 4.23M -0.71362M 0.53M
Begin period cash flow 2.80M 5.26M 1.02M 1.74M 1.21M
End period cash flow 2.16M 2.80M 5.26M 1.02M 1.74M
Total cash from operating activities -2.19379M -2.53170M -2.18933M -1.63450M -2.67832M
Issuance of capital stock 1.61M - 7.49M 1.13M 3.08M
Depreciation - 0.43M 0.49M 0.46M 0.42M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.06655M 0.24M -0.22881M 0.28M -0.38084M
Change to account receivables 0.11M -0.27545M 0.18M 0.08M -0.18523M
Sale purchase of stock -0.06620M - -0.43197M -0.06092M -0.08830M
Other cashflows from financing activities -0.04970M -0.00266M -0.09752M 0.41M -0.08830M
Change to netincome -0.00844M 4.62M 0.30M 2.50M 0.25M
Capital expenditures 0.05M 0.00266M 0.10M 0.10M 0.41M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - 0.20M -0.10214M 0.01M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -0.04970M -0.00266M -0.09752M -1.63450M -3.08835M

Fundamentals

  • Previous Close 0.02
  • Market Cap9.09M
  • Volume9012
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.88680M
  • Revenue TTM2.23M
  • Revenue Per Share TTM0.006
  • Gross Profit TTM 1.00M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TRU
Truscreen Ltd
- -% 0.02 - - 4.78 7.81 4.54 -2.5646
COH
Cochlear Ltd
-6.03 1.83% 324.36 62.10 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd
-0.02 0.96% 2.06 - 140.85 17.37 21.49 17.51 647.42
AVR
Anteris Technologies Ltd
-0.26 1.33% 19.35 - - 104.23 14.98 95.15 -5.9152
EBR
Ebr Systems Inc CDR
0.05 4.81% 1.09 - - - 5.68 - -7.482

Reports Covered

Stock Research & News

Profile

Truscreen Group Limited, together with its subsidiaries, engages in the development, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.

Truscreen Ltd

Equitable House, Auckland, New Zealand, 1010

Key Executives

Name Title Year Born
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), C.A., CA, MAICD CFO & Company Sec. 1954
Mr. Edmond Capcelea Chief Technology Officer NA
Dr. Beata Niechoda Edling Chief Exec. Officer NA
Dr. . Phunc Head of Cancer Department NA
Dr. . Chuong Head of R&D and Training Department NA
Dr. . Thuy Head of High Service Gynaecology Examination NA
Dr. Beata Niechoda Edling Chief Executive Officer NA
Dr. Beata Niechoda Edling Chief Executive Officer NA
Dr. Beata Niechoda Edling Chief Executive Officer NA
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD CFO & Company Secretary 1953

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).